Yoshihiro Tanaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yoshihiro Tanaka has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Hirokazu Mizuno
Division of Central Radiology, Osaka Rosai Hospital, 1179-3 Nagasone-cho, Kita-ku, Sakai-shi, Osaka, 591-8025, Japan
3 shared publicationsMasaru Isono
Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka-shi, Osaka, 541-8567, Japan
3 shared publicationsToshijiro Yamamoto
Department of Radiation Therapy, Saiseikai Noe Hospital, 1-3-25 Furuichi, Joto-ku, Osaka-shi, Osaka, 536-0001, Japan
3 shared publicationsNorihisa Masai
Miyakojima IGRT Clinic, 1-16-22 Miyakojimahondori, Miyakojima-ku, Osaka-shi, Osaka, 534-0021, Japan
2 shared publicationsYuichi Akino
Oncology Center, Osaka University Hospital, 2-2 (D10), Yamada-oka, Suita-shi, Osaka, 565-0871, Japan
2 shared publicationsErika Uta
Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, 1-7 Yamada-oka, Suita-shi, Osaka, 565-0871, Japan
1 shared publication
Latest Publications
- 8 June 2020
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 43 (3) , 889-901
Collection and analysis of photon beam data for Varian C-series linear accelerators: a potential reference beam data set
This study aimed to collect and analyze photon beam data for the Varian C-series linear accelerators (Varian Medical Systems, Palo Alto, CA, USA). We evaluated the potential of the average data to be used as reference beam data for the radiotherapy treatment planning system commissioning verification. We collected 20 data sets for 4 and 6 MV photon beams, and 40 data sets for a 10 MV photon beam generated by the Varian C-series machines, which contained the percent depth dose (PDD), off-center ratio (OCR), and output factor (OPF) from 20 institutions. The average for each of the data types was calculated across the 20 machines. Dose differences from the average for PDD at the dose fall-off region were less than 1.0%. Relative differences from the average for the OPF data were almost within 1.0% for all energies and field sizes. For OCR data in the flat regions, the standard deviation of the dose differences from the average was within 1.0%, excluding that of the 30 × 30 mm2 field size being approximately 1.5%. For all energies and field sizes, the distance to agreement from the average in the OCR penumbra regions was less than 1.0 mm. The average data except for the small field size found in this study can be used as reference beam data for verifying users’ commissioning results.
- 8 June 2020
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 43 (3) , 889-901
Collection and analysis of photon beam data for Varian C-series linear accelerators: a potential reference beam data set
This study aimed to collect and analyze photon beam data for the Varian C-series linear accelerators (Varian Medical Systems, Palo Alto, CA, USA). We evaluated the potential of the average data to be used as reference beam data for the radiotherapy treatment planning system commissioning verification. We collected 20 data sets for 4 and 6 MV photon beams, and 40 data sets for a 10 MV photon beam generated by the Varian C-series machines, which contained the percent depth dose (PDD), off-center ratio (OCR), and output factor (OPF) from 20 institutions. The average for each of the data types was calculated across the 20 machines. Dose differences from the average for PDD at the dose fall-off region were less than 1.0%. Relative differences from the average for the OPF data were almost within 1.0% for all energies and field sizes. For OCR data in the flat regions, the standard deviation of the dose differences from the average was within 1.0%, excluding that of the 30 × 30 mm2 field size being approximately 1.5%. For all energies and field sizes, the distance to agreement from the average in the OCR penumbra regions was less than 1.0 mm. The average data except for the small field size found in this study can be used as reference beam data for verifying users’ commissioning results.
- Open Access
- 9 December 2019
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 21 (1) , 78-87
Small‐field dosimetry of TrueBeamTM flattened and flattening filter‐free beams: A multi‐institutional analysis
Purpose Detector‐dependent interinstitutional variations of the beam data may lead to uncertainties of the delivered dose to patients. Here we evaluated the inter‐unit variability of the flattened and flattening filter‐free (FFF) beam data of multiple TrueBeam (Varian Medical Systems) linear accelerators focusing on the small‐field dosimetry. Methods The beam data of 6‐ and 10‐MV photon beams with and without flattening filter measured for modeling of an iPLAN treatment planning system (BrainLAB) were collected from 12 institutions — ten HD120 Multileaf Collimator (MLC) and two Millennium120 MLC. Percent‐depth dose (PDD), off‐center ratio (OCR), and detector output factors (OFdet) measured with different detectors were evaluated. To investigate the detector‐associated effects, we evaluated the inter‐unit variations of the OFdet before and after having applied the output correction factors provided by the International Atomic Energy Agency (IAEA) Technical Reports Series no. 483. Results PDD measured with a field size of 5 × 5 mm2 showed that the data measured using an ionization chamber had variations exceeding 1% from the median values. The maximum difference from median value was 2.87% for 10 MV photon beam. The maximum variations of the penumbra width for OCR with 10 × 10 mm2 field size were 0.97 mm. The OFdet showed large variations exceeding 15% for a field size of 5 × 5 mm2. When the output correction factors were applied to the OFdet, the variations were greatly reduced. The relative difference of almost all field output factors were within ± 5% from the median field output factors. Conclusion In this study, the inter‐unit variability of small‐field dosimetry was evaluated for TrueBeam linear accelerators. The variations were large at a field size of 5 × 5 mm2, and most occurred in a detector‐dependent manner.
- 9 December 2019
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 21 (1) , 78-87
Open AccessSmall‐field dosimetry of TrueBeamTM flattened and flattening filter‐free beams: A multi‐institutional analysis
Purpose Detector‐dependent interinstitutional variations of the beam data may lead to uncertainties of the delivered dose to patients. Here we evaluated the inter‐unit variability of the flattened and flattening filter‐free (FFF) beam data of multiple TrueBeam (Varian Medical Systems) linear accelerators focusing on the small‐field dosimetry. Methods The beam data of 6‐ and 10‐MV photon beams with and without flattening filter measured for modeling of an iPLAN treatment planning system (BrainLAB) were collected from 12 institutions — ten HD120 Multileaf Collimator (MLC) and two Millennium120 MLC. Percent‐depth dose (PDD), off‐center ratio (OCR), and detector output factors (OFdet) measured with different detectors were evaluated. To investigate the detector‐associated effects, we evaluated the inter‐unit variations of the OFdet before and after having applied the output correction factors provided by the International Atomic Energy Agency (IAEA) Technical Reports Series no. 483. Results PDD measured with a field size of 5 × 5 mm2 showed that the data measured using an ionization chamber had variations exceeding 1% from the median values. The maximum difference from median value was 2.87% for 10 MV photon beam. The maximum variations of the penumbra width for OCR with 10 × 10 mm2 field size were 0.97 mm. The OFdet showed large variations exceeding 15% for a field size of 5 × 5 mm2. When the output correction factors were applied to the OFdet, the variations were greatly reduced. The relative difference of almost all field output factors were within ± 5% from the median field output factors. Conclusion In this study, the inter‐unit variability of small‐field dosimetry was evaluated for TrueBeam linear accelerators. The variations were large at a field size of 5 × 5 mm2, and most occurred in a detector‐dependent manner.
- 1 November 2019
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 24 (6) , 576-584
Dose distribution comparison in volumetric-modulated arc therapy plans for head and neck cancers with and without an external body contour extended technique
This study compared volumetric-modulated arc therapy (VMAT) plans for head and neck cancers with and without an external body contour extended technique (EBCT). Dose calculation algorisms for VMAT have limitations in the buildup region. Three VMAT plans were enrolled, with one case having a metal artifact from an artificial tooth. The proper dose was calculated using Eclipse version 11.0. The body contours were extended 2 cm outward from the skin surface in three-dimensional space, and the dose was recalculated with an anisotropic analytical algorithm (AAA) and Acuros XB (AXB). Monitor units (MUs) were set, and the dose distributions in the planning target volume (PTV), clinical target volume, and organ at risk (OAR) and conformity index (CI) with and without an EBCT were compared. The influence of a metal artifact outside of the thermoplastic head mask was also compared. The coverage of PTV by the 95% dose line near the patient's skin was increased drastically by using an EBCT. Plan renormalization had a negligible impact on MUs and doses delivered to OARs. CI of PTV with a 6-MV photon beam was closer to 1 than that with a 10-MV photon beam when both AAA and AXB were used in all cases. Metal artifacts outside the head mask had no effect on dose distribution. An EBCT is needed to estimate the proper dose at object volumes near the patient's skin and can improve the accuracy of the calculated dose at target volumes.
- 1 November 2019
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 24 (6) , 576-584
Dose distribution comparison in volumetric-modulated arc therapy plans for head and neck cancers with and without an external body contour extended technique
This study compared volumetric-modulated arc therapy (VMAT) plans for head and neck cancers with and without an external body contour extended technique (EBCT). Dose calculation algorisms for VMAT have limitations in the buildup region. Three VMAT plans were enrolled, with one case having a metal artifact from an artificial tooth. The proper dose was calculated using Eclipse version 11.0. The body contours were extended 2 cm outward from the skin surface in three-dimensional space, and the dose was recalculated with an anisotropic analytical algorithm (AAA) and Acuros XB (AXB). Monitor units (MUs) were set, and the dose distributions in the planning target volume (PTV), clinical target volume, and organ at risk (OAR) and conformity index (CI) with and without an EBCT were compared. The influence of a metal artifact outside of the thermoplastic head mask was also compared. The coverage of PTV by the 95% dose line near the patient's skin was increased drastically by using an EBCT. Plan renormalization had a negligible impact on MUs and doses delivered to OARs. CI of PTV with a 6-MV photon beam was closer to 1 than that with a 10-MV photon beam when both AAA and AXB were used in all cases. Metal artifacts outside the head mask had no effect on dose distribution. An EBCT is needed to estimate the proper dose at object volumes near the patient's skin and can improve the accuracy of the calculated dose at target volumes.
- Open Access
- 13 January 2019
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 20 (2) , 51-62
Do the representative beam data for TrueBeam™ linear accelerators represent average data?
If the vendor's representative beam data (RBD) for TrueBeam linear accelerators are to be valid for use in clinical practice, the variations in the beam data used for beam modeling must be small. Although a few studies have reported the variation of the beam data of the TrueBeam machines, the numbers of machines analyzed in those studies were small. In this study, we investigated the variation in the beam data for 21 TrueBeam machines collected from 17 institutions with their agreement. In the exponential regions, the percent depth dose (PDD) values showed very small variation, 2. The maximum distance‐to‐agreement from the average data was 2. The OPF of the average study data also showed good agreement with the vendor's RBD for all field sizes. However, although all the institutions used ionization chambers with similar cavity volumes, the 30 × 30 mm2 field size showed large DD variations (≥2%) in OCR in the field regions. We conclude that the intermachine variability of TrueBeam linear accelerators was very small except for small field dosimetry, supporting the validity of the use of the RBD for clinical applications. The use of the vendor's RBD might greatly facilitate the quick installation of a new linear accelerator.
- 13 January 2019
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 20 (2) , 51-62
Open AccessDo the representative beam data for TrueBeam™ linear accelerators represent average data?
If the vendor's representative beam data (RBD) for TrueBeam linear accelerators are to be valid for use in clinical practice, the variations in the beam data used for beam modeling must be small. Although a few studies have reported the variation of the beam data of the TrueBeam machines, the numbers of machines analyzed in those studies were small. In this study, we investigated the variation in the beam data for 21 TrueBeam machines collected from 17 institutions with their agreement. In the exponential regions, the percent depth dose (PDD) values showed very small variation, 2. The maximum distance‐to‐agreement from the average data was 2. The OPF of the average study data also showed good agreement with the vendor's RBD for all field sizes. However, although all the institutions used ionization chambers with similar cavity volumes, the 30 × 30 mm2 field size showed large DD variations (≥2%) in OCR in the field regions. We conclude that the intermachine variability of TrueBeam linear accelerators was very small except for small field dosimetry, supporting the validity of the use of the RBD for clinical applications. The use of the vendor's RBD might greatly facilitate the quick installation of a new linear accelerator.